Ad is loading...
ARRY
Price
$6.37
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
109 days until earnings call
IBRX
Price
$5.04
Change
+$0.15 (+3.07%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

ARRY vs IBRX

Header iconARRY vs IBRX Comparison
Open Charts ARRY vs IBRXBanner chart's image
Array Technologies
Price$6.37
Change-$0.00 (-0.00%)
Volume$5.95M
CapitalizationN/A
ImmunityBio
Price$5.04
Change+$0.15 (+3.07%)
Volume$3.37M
CapitalizationN/A
ARRY vs IBRX Comparison Chart
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ARRY vs. IBRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongSell and IBRX is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (IBRX: $5.03)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IBRX’s FA Score shows that 1 FA rating(s) are green while.

  • IBRX’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 3 TA indicator(s) are bullish while IBRX’s TA Score has 5 bullish TA indicator(s).

  • ARRY’s TA Score: 3 bullish, 5 bearish.
  • IBRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than ARRY.

Price Growth

IBRX (@Biotechnology) experienced а +3.39% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

IBRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($3.51B) has a higher market cap than ARRY($2.22B). IBRX YTD gains are higher at: 0.299 vs. ARRY (-62.321). ARRY has higher annual earnings (EBITDA): 276M vs. IBRX (-421.03M). ARRY has more cash in the bank: 249M vs. IBRX (130M). ARRY (730M) and IBRX (743M) have identical debt. ARRY has higher revenues than IBRX: ARRY (1.58B) vs IBRX (7.33M).
ARRYIBRXARRY / IBRX
Capitalization2.22B3.51B63%
EBITDA276M-421.03M-66%
Gain YTD-62.3210.299-20,857%
P/E Ratio26.23N/A-
Revenue1.58B7.33M21,508%
Total Cash249M130M192%
Total Debt730M743M98%
FUNDAMENTALS RATINGS
ARRY vs IBRX: Fundamental Ratings
ARRY
IBRX
OUTLOOK RATING
1..100
1182
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
8441
P/E GROWTH RATING
1..100
43100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (4) in the Biotechnology industry is significantly better than the same rating for ARRY (87). This means that IBRX’s stock grew significantly faster than ARRY’s over the last 12 months.

IBRX's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as ARRY (100). This means that IBRX’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's SMR Rating (98) in the Biotechnology industry is in the same range as IBRX (100). This means that ARRY’s stock grew similarly to IBRX’s over the last 12 months.

IBRX's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for ARRY (84). This means that IBRX’s stock grew somewhat faster than ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for IBRX (100). This means that ARRY’s stock grew somewhat faster than IBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYIBRX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMUSX25.560.17
+0.67%
Franklin U.S. Large Cap Equity FI
VWIGX35.730.10
+0.28%
Vanguard International Growth Inv
DREGX37.60N/A
N/A
Driehaus Emerging Markets Growth Inv
PABFX18.67N/A
N/A
PGIM Balanced Z
SFREX9.71N/A
N/A
Schwab Fundamental Global Real Estt Idx

ARRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARRY has been closely correlated with SHLS. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARRY jumps, then SHLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRY
1D Price
Change %
ARRY100%
-0.63%
SHLS - ARRY
66%
Closely correlated
-0.23%
FSLR - ARRY
61%
Loosely correlated
-1.56%
NXT - ARRY
59%
Loosely correlated
-0.51%
RUN - ARRY
57%
Loosely correlated
+0.20%
AXON - ARRY
53%
Loosely correlated
+3.52%
More

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
+3.28%
AXON - IBRX
48%
Loosely correlated
+3.52%
ARRY - IBRX
41%
Loosely correlated
-0.63%
AMRN - IBRX
37%
Loosely correlated
+6.17%
RXRX - IBRX
37%
Loosely correlated
-4.80%
VCYT - IBRX
35%
Loosely correlated
-0.66%
More